Physician profile
Albert Triana
NPI 1851501449
$3,847.25
in general payments reported to CMS, 2019-2025
28 companies · $673 in 2025
The $673 reported for 2025 was more than what 86% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $318 · 2020: $314 · 2021: $652 · 2022: $987 · 2023: $519 · 2024: $385 · 2025: $673.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,577.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,577.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ethicon US, LLC | $718.35 | 2020-2023 | Ethicon, Endopath |
| Hologic Sales and Service, LLC | $674.83 | 2019-2025 | Acessa Provu System, Thinprep 2000 Processor, Aptima |
| Abbvie INC. | $525.39 | 2019-2023 | Lo Loestrin Fe, Orilissa |
| Mayne Pharma Commercial LLC | $342.62 | 2021-2025 | |
| Medical Device Business Services, INC. | $272.93 | 2022-2025 | Harmonic |
| Shield Therapeutics INC | $199.45 | 2022-2025 | Accrufer |
| Coopersurgical, INC. | $163.42 | 2021-2025 | Paragard T 380a, Wallach Cryosurgical Equipment, Ally II Ups |
| Bayer Healthcare Pharmaceuticals INC. | $128.39 | 2019-2025 | |
| Amag Pharmaceuticals, INC. | $124.60 | 2019-2021 | |
| Astellas Pharma US INC | $86.59 | 2023-2024 | Veozah |
| Avion Pharmaceuticals | $85.71 | 2019-2021 | |
| Evofem Biosciences, INC. | $79.48 | 2021-2025 | Phexxi, Solosec, Phexx |
| Therapeuticsmd, INC. | $79.29 | 2019-2022 | |
| Ge Healthcare | $36.30 | 2020 | |
| Covidien LP | $36.07 | 2019 |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $33.23 | 2019 | |
| Meditrina | $31.30 | 2021 | |
| Organon LLC | $30.59 | 2022-2024 | |
| Agile Therapeutics, INC. | $24.97 | 2022 | |
| Olympus America INC. | $24.32 | 2023 | |
| Pfizer INC. | $24.12 | 2025 | |
| Smith+Nephew, INC. | $24.11 | 2024 | Pico 14 |
| Mylan Pharmaceuticals INC. | $23.55 | 2022 | |
| Myovant Sciences INC. | $19.64 | 2021 | |
| Axonics, INC. | $17.20 | 2021 | |
| Lupin INC. | $16.37 | 2019 | |
| Optumhealth Care Solutions, LLC | $14.11 | 2025 | Vivify Health Care Team Portal 001, Eitan Medical |
| Kerecis Limited | $10.32 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide, Kerecis Omega3 Marigen |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Albert Triana listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.